The Federal Circuit confirms in the precedential decision Ariad Pharmaceuticals Inc. v. Eli Lilly and Company, that the written description requirement of 35 U.S.C. § 112, first paragraph is here to stay.
Please
click here for a PDF of the Case Law Update.
